Dr. Reddy's Laboratories allotted 3,675 equity shares of Re.1 each on March 26, 2026, under its ADR Stock Options Scheme, 2007.
Shares were issued at two exercise prices: 575 shares at Re.1 each and 3,100 shares at Rs.735.80 each.
Post-allotment, total paid-up equity share capital stands at 83,46,56,970 shares aggregating to Rs.83,46,56,970.